Researchers conducted a meta-analysis of three population-based studies involving people with Parkinson's disease of European ancestry. The study looked at how specific genetic markers and a general polygenic risk score for depression might relate to a diagnosis of depression or its symptoms.
The findings showed a significant link between a specific gene called KRTCAP2 and a higher likelihood of depression. Patients with a higher genetic burden in this gene had 20 percent higher odds of being diagnosed with depression. Additionally, a general polygenic risk score for depression was significantly associated with a higher likelihood of a depression diagnosis across the study groups.
Other genes, such as TRAF5 and LRRK2, showed only marginal links. It is important to note that these findings show an association between genes and symptoms, not a direct cause. Because this is a meta-analysis of population studies, the results help identify potential genetic contributors but do not provide a definitive diagnosis or treatment plan for individuals.
